Related Experiment Video
Updated: Jun 1, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Adjuvant treatment for stage IIIC endometrial cancer: options and controversies
Pratish H Shah1, Mahesh Kudrimoti, Jonathan Feddock
1University of Kentucky Medical Center, Department of Radiation Medicine, 800 Rose Street, Room C-31, Lexington, KY 40536-0293, USA.
Abstract:
Endometrial cancer is the most common gynecologic malignancy. Locally advanced and high risk endometrial cancer encompasses a heterogeneous group of patients and optimal treatment for various sub-groups of these patients remains controversial. Stage IIIC is the most common sub-stage of patients with locally advanced endometrial carcinoma. This article reviews retrospective and prospective data of various adjuvant treatment approaches involving chemotherapy, radiation therapy, or combined modality therapy, including the recently proposed "sandwich" regimens that have yielded encouraging results. Areas of controversy are also discussed to assist clinicians in identifying the most effective adjuvant treatment regimens for patients with locally advanced disease. On-going randomized trials are briefly discussed.
Related Concept Videos
Treatment Resistant Cancers
Treatment Resistent Cancers
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
